Structural Formula (Figure 1 Structure)
Oxybutynin Chloride Tablet
Product Images NDC 10702-201
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 10702-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Kvk-tech, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1000s Label (Figure 10 1000s Label)
This is a medication description for Oxybutynin Chioride USP tablets containing 5mg of the active ingredient. The recommended dosage is one tablet for adults two to four times a day and for pediatric patients, one tablet two or three times a day. The tablets should be dispensed in a light-resistant container and stored between 20°C to 25°C (68°F to 77°F). This medication is only available through prescription and should be kept out of reach of children. The manufacturer is KVK-Tech Inc. based in Newtown, PA.*
Table 1 (Figure 2 Table1)
This appears to be a table indicating the results of a comparison of two parameters (R-Oybutynin and S-Ouybutynin) in terms of their G, Toa, AUC, and UGy values. The units of measurement are not immediately clear. The values for the two parameters appear to vary significantly across all four categories.*
Figure 1 (Figure 3 Figure1)
Table 2 (Figure 4 Table2)
Figure 2 (Figure 5 Figure2)
Table 3 (Figure 6 Table3)
Oxybutynin Chloride is a drug that may cause adverse events in multiple body systems such as infections, psychiatric disorders, nervous system disorders, eye disorders, gastrointestinal disorders, and renal and urinary disorders. These events include urinary tract infection, insomnia, nervousness, dizziness, somnolence, blurred vision, dry mouth, constipation, nausea, dyspepsia, urinary hesitation, and urinary retention. The percentages represent how often these events occurred in clinical trials.*
Kvk Logo (Figure 7 Company Logo)
100s Label (Figure 8 100s Label)
Each tablet contains Oxybutynin Chloride at a strength of 5mg. The tablets are USP 0sperseinatos sptessontconsosr s s. They should be stored at temperatures between 15°C to 37°C (60 to 98°F). The pack has 100 tablets and the tablets can be identified by NOG 10702.201-01 and NDC 10702-201-01. The product should be kept out of children's reach.*
500s Label (Figure 9 500s Label)
This is a description of Oxybutynin Chloride Tablets, USP with 5mg strength. It is a prescription drug by KVK and is to be taken one tablet two to four times a day by adults, and one tablet two to three times a day by pediatric patients with precautions. It is recommended to store in a light-resistant container as defined in the USPIN and keep out of the reach of children. The manufacturer of this drug is KVICToch, Inc, located in Newtown, PA 16940.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
